Gladstone Institutes Announces Andrew S. Garb’s Transition to Emeritus Trustee
After more than four decades of dedicated legal and governance leadership, including 22 years as a trustee, Garb will transition to emeritus status in 2027.
Gladstone Institutes today announced that Andrew S. Garb has decided to transition from his role as trustee to emeritus trustee in April 2027. Garb’s leadership spans more than four decades of service to Gladstone, during which he played a vital role in guiding the independent biomedical research organization’s governance, strategic vision, and financial strength.
Garb’s connection to Gladstone dates back to 1981, when he was named legal counsel to the founding Gladstone trustees. He was appointed trustee designate in 1995 and officially named a trustee in 2004, replacing founding trustee Richard Brawerman and becoming one of only seven trustees in Gladstone’s history. Throughout his tenure, Garb’s steady leadership in high-level governance, asset management, and executive oversight helped foster an environment where transformative scientific discovery could thrive.
Andy’s contributions to Gladstone over the past 40-plus years are immeasurable. We are profoundly grateful for his stewardship and thrilled that he will continue to share his guidance with us as emeritus trustee.
Deepak Srivastava, MD
“Andy’s contributions to Gladstone over the past 40-plus years are immeasurable,” says Deepak Srivastava, MD, president of Gladstone. “From his early days as legal counsel to his more-than two decades as trustee, his wisdom, strategic clarity, and deep commitment to our mission have helped shape Gladstone into the world-class institute it is today. We are profoundly grateful for his stewardship and thrilled that he will continue to share his guidance with us as emeritus trustee.”
Gladstone is rare among scientific research organizations in that it’s structured as a trust, not a corporation. This streamlined leadership structure—always with three trustees at the helm— gives Gladstone the ability to follow the science where it leads without red tape or unnecessary layers of approval. Garb currently serves alongside fellow trustees William S. Price III and Nicholas J. Simon.
“It has been one of the great privileges of my career to serve Gladstone Institutes and support its exceptional community of scientists,” Garb says. “Gladstone’s unique trust structure allows for bold, agile decision-making that turns ambitious ideas into life-saving research. I look forward to remaining engaged with this great organization in coming years and continuing to support its incredible scientific mission.”
Operating from the epicenter of innovation in San Francisco, Gladstone invents and deploys cutting-edge tools—including AI, CRISPR, and iPS cell technologies—across cardiology, neurology, infectious diseases, and immunotherapy for cancer and autoimmune diseases. Through this, Gladstone’s 600-plus scientists are driving a new era of discovery—an era in which it’s possible to prevent or even cure the world’s most intractable diseases.
It is impossible to overstate the role Andy has played at Gladstone over four decades of service. His dedication to building a great culture, hiring exceptional people, and finding the resources to empower breakthrough science has been transformative.
William S. Price III
“It is impossible to overstate the role Andy has played at Gladstone over four decades of service,” says Price, who has served with Garb as a Gladstone trustee since 2016. “His dedication to building a great culture, hiring exceptional people, and finding the resources to empower breakthrough science has been transformative.”
Indeed, Garb has played a crucial role in guiding Gladstone to become one of the world’s preeminent nonprofit research institutions. Prior to focusing his efforts on philanthropic governance, Garb enjoyed a distinguished legal career. In 2022, he retired from the Los Angeles law firm Loeb & Loeb LLP, where he served as managing partner from 1986 to 1992. His legal practice included representing high-profile clients and estates, such as J. Paul Getty, Jr., the Conrad Hilton Foundation, the William Randolph Hearst Trust, Cedars-Sinai Medical Center, Motion Picture & Television Fund, and the estates of Gene Roddenberry and Frank Sinatra. A fellow of the American College of Trust and Estate Counsel, Garb published and lectured extensively on trust and estate law. He earned his law degree from Harvard in 1967 and a master’s degree in law from the University of Southern California, following a teaching and research assistantship at Yale Law School.
Beyond his work with Gladstone, Garb maintains an active role in philanthropic leadership. He currently serves as director of the Roddenberry Foundation, which supports Gladstone’s Roddenberry Stem Cell Center, is director of the Kane Educational and Research Foundation, and until recently was director of Whittier Trust Company. He previously co-founded and chaired the board of the Success Through the Arts Foundation, served as board president of the Greater Los Angeles chapter of the Crohn’s and Colitis Foundation and sat on its National Grants Review Committee, and was president of Kehillat Israel Synagogue in Pacific Palisades.
To support Gladstone’s next chapter of growth—particularly as the organization prepares to expand into more than 100,000 square feet of additional lab and office space at 1450 Owens Street in San Francisco—Gladstone plans to welcome a new trustee in spring of 2027.
For Media
About Gladstone
Gladstone Institutes is an independent, nonprofit life science research organization that uses visionary science and technology to overcome disease. Established in 1979, it is located in the epicenter of biomedical and technological innovation, in the Mission Bay neighborhood of San Francisco. Gladstone has created a research model that disrupts how science is done, funds big ideas, and attracts the brightest minds.
Up Next
How AI Is Filling the Gaps in Women’s Health Research
A Gladstone-led study is collecting data from thousands of women wearing Oura Rings to make sense of what’s normal—and what could signal problems—when it comes to the menstrual cycle.
Christina Theodoris to Receive ASCI’s 2026 Seldin-Smith Award for Pioneering Research
The prestigious honor is presented by the American Society for Clinical Investigation to a physician-scientist making transformative contributions to biomedical research.
Gladstone’s Melanie Ott and Alex Marson Elected to the National Academy of Medicine
Physician-scientists and directors at Gladstone Institutes, Ott and Marson are honored for their pioneering achievements in science and medicine.
In Alzheimer’s Disease, the Brain’s Pacemaker Cells Lose Their Beat
Research in mice reveals how critical brain cells misfire in Alzheimer’s and identifies a targeted strategy to restore healthy brain rhythms.
Get Involved
Join the Team
Our people are our most important asset. We offer a wide array of career opportunities both in our administrative offices and in our labs.
Open PositionsPartner With Us
Discoveries don’t stay in our labs. Gladstone facilitates spinout companies to advance promising therapies, shortening the path between scientific discovery and helping real patients.
Learn MoreGive
Your gift to Gladstone will allow our researchers to pursue high-quality science, focus on disease, and train the next generation of scientific thought leaders.
Donate Now